| Product Code: ETC12838631 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Guatemala saw a steady increase in the import of influenza medications, with top exporting countries being India, Mexico, Spain, Germany, and Argentina. The market remained competitive with a low concentration level, indicating a diverse range of sources for these essential pharmaceutical products. The impressive Compound Annual Growth Rate (CAGR) of 17.03% from 2020 to 2024 highlights the growing demand for influenza medications in Guatemala. Additionally, the growth rate of 9.41% from 2023 to 2024 suggests a sustained momentum in the market, making it an attractive sector for pharmaceutical companies looking to expand their reach in the region.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Guatemala Influenza Medications Market Overview |
3.1 Guatemala Country Macro Economic Indicators |
3.2 Guatemala Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Guatemala Influenza Medications Market - Industry Life Cycle |
3.4 Guatemala Influenza Medications Market - Porter's Five Forces |
3.5 Guatemala Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Guatemala Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Guatemala Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Guatemala Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of flu vaccinations |
4.2.2 Growing prevalence of influenza cases in Guatemala |
4.2.3 Government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost of influenza medications |
4.3.2 Limited access to healthcare services in rural areas of Guatemala |
5 Guatemala Influenza Medications Market Trends |
6 Guatemala Influenza Medications Market, By Types |
6.1 Guatemala Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Guatemala Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Guatemala Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Guatemala Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Guatemala Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Guatemala Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Guatemala Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Guatemala Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Guatemala Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Guatemala Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Guatemala Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Guatemala Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Guatemala Influenza Medications Market Import-Export Trade Statistics |
7.1 Guatemala Influenza Medications Market Export to Major Countries |
7.2 Guatemala Influenza Medications Market Imports from Major Countries |
8 Guatemala Influenza Medications Market Key Performance Indicators |
8.1 Percentage increase in flu vaccination rates |
8.2 Number of reported influenza cases in Guatemala |
8.3 Adoption rate of generic influenza medications |
9 Guatemala Influenza Medications Market - Opportunity Assessment |
9.1 Guatemala Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Guatemala Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Guatemala Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Guatemala Influenza Medications Market - Competitive Landscape |
10.1 Guatemala Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Guatemala Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here